Provided by Tiger Trade Technology Pte. Ltd.

BioLine Rx

2.53
+0.05002.02%
Volume:11.87K
Turnover:29.47K
Market Cap:12.27M
PE:-1.60
High:2.63
Open:2.63
Low:2.43
Close:2.48
52wk High:4.56
52wk Low:2.15
Shares:4.85M
Float Shares:4.59M
Volume Ratio:0.82
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5822
EPS(LYR):-0.2856
ROE:-55.27%
ROA:-19.82%
PB:0.89
PE(LYR):-8.86

Loading ...

Israel's BioLineRx Q2 Net Loss Widens on Higher R&D Expenses

Reuters
·
Aug 31

BioLine Rx Q2 Sales $294.000K Miss $500.000K Estimate

Benzinga Earnings
·
Aug 31

Press Release: BioLineRx Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
Aug 31

BioLine RX Ltd Expected to Post Breakeven Results a Share - Earnings Preview

Reuters
·
Aug 28

BioLineRx, Hemispherian announces new preclinical data on GLIX1, PARP inhibitor

TIPRANKS
·
Jul 08

JonesTrading Reaffirms Their Buy Rating on Bioline RX Ltd Sponsored ADR (BLRX)

TIPRANKS
·
Jun 02

Analysts Offer Insights on Healthcare Companies: Bioline RX Ltd Sponsored ADR (BLRX), BeOne Medicines (ONC) and Autonomix Medical, Inc. (AMIX)

TIPRANKS
·
Jun 02

BioLine Rx Q1 Sales $477.000K Beat $343.000K Estimate

Benzinga Earnings
·
May 27

Press Release: BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
May 27

BioLine RX Ltd expected to post a loss of $1.04 a share - Earnings Preview

Reuters
·
May 25

BioLineRx and Hemispherian report new GLIX1 anti-tumor effect in GBM

TIPRANKS
·
May 19

BioLine Rx Q4 EPADS $(0.34) Beats $(0.54) Estimate, Sales $194.000K Miss $651.598K Estimate

Benzinga Earnings
·
Mar 24

BioLine Rx Q4 Sales $194.000K Miss $651.598K Estimate

Benzinga Earnings
·
Mar 23

Press Release: BioLineRx Reports 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Mar 23

BioLine RX Ltd expected to post a loss of 77 cents a share - Earnings Preview

Reuters
·
Mar 20

Top Wall Street Forecasters Revamp BioLineRx Expectations Ahead Of Q4 Earnings

Benzinga_recent_news
·
Mar 20

BioLine RX Ltd expected to post a loss of 77 cents a share - Earnings Preview

Reuters
·
Mar 17